DSG Press Releases

CNRM AND DSG BATTLE U.S. TROOPS’ TRAUMATIC BRAIN INJURY — DSG’s electronic data capture
is used by CNRM in critical traumatic brain injury studies in an effort to better understand and combat leading medical setbacks.

The Center for Neuroscience and Regenerative Medicine (CNRM) is using DSG’s eCaseLink™ EDC (electronic data capture) system in three key studies on traumatic brain injury (TBI) in an effort to properly classify, diagnose, and combat one of the leading medical issues for U.S. military troops and veterans.

DSG PARTNERS WITH BIO-TECH COMPANY TO BATTLE PROGRESSIVE AND CHRONIC KIDNEY DISEASE

DSG’s eCaseLink™ Electronic Data Capture (EDC) and data management are currently being used by a biotechnology company for two current phase 2 and phase 2a clinical trials for treatments of progressive and chronic kidney disease. The bio-tech company uses DSG’s eCaseLink™ to automate and manage the data collection process during the clinical trial life cycle. In addition, DSG combines data management services with eCaseLink™ to seamlessly optimize data collection and analysis.

DSG & PHARMACEUTICAL COMPANY ENGAGE IN GLOBAL EFFORT IN EARLY DETECTION OF MAJOR DISEASES.

EDC technology supports studies on early detection for Alzheimer’s, Parkinson’s and Diabetes. DSG, a leader in electronic data capture (EDC) has teamed up with a leading-edge pharmaceutical company to speed the early detection of Alzheimer’s, Parkinson’s, and Diabetes.
The focus is on developing molecular imaging products that are leading the way to the early detection of human diseases. DSG’s eCaseLink™ EDC (Electronic Data Capture) supports three current clinical trials for Alzheimer’s disease, Parkinson’s disease and Diabetes. eCaseLink™ supplies real-time capability to review case documents and metrics across all study sites, significantly increasing clinical trial management speed, while reducing study management costs by as much as 30 percent.

DSG SPARKS DIALOGUE, DEMONSTRATES VISION AT 2009 SCDM ANNUAL CONFERENCE — DSG’s EDC presence at 2009 SCDM conference delivered on high expectations

DSG, Inc., the leader in EDC and clinical software technology, sparked a robust dialogue and inspired attendees at the 2009 SCDM Annual Conference in Seattle recently, again proving its role as a pioneer in the EDC (electronic data capture) field. Over 500 eager attendees experienced the latest EDC developments, learned how to successfully navigate a critical industry challenge and saw the future of EDC from DSG.

DSG IN THE SPOTLIGHT AT 2009 SCDM ANNUAL CONFERENCE

DSG, Inc., the leader in EDC and clinical software technology, is already the center of attention leading up to the 2009 SCDM Annual Conference. The excitement is centered around DSG’s continuing role as a pioneer in the EDC (electronic data capture) field, with over 500 attendees eager to see the latest developments and the future of EDC from DSG.

CIPHER USES DSG’S EDC IN EFFORT TO GIVE HOPE TO SEVERE ACNE SUFFERERS

DSG Inc., an industry leader in clinical trial data collection and management, today announced that Cipher Pharmaceuticals (TSX: DND) is using electronic data capture (EDC) software and data management services from DSG. Cipher is using DSG’s eCaseLink™ for its Phase 3 dermatology study on its new compound for the treatment of severe acne.

DSG TOPS CLINICAL TRIAL MARKET ON THE INC. 500

The Inc. 500, which ranks the fastest growing U.S. privately held companies, announced that DSG reached No. 82 in the nation, making it the fastest growing privately held company in the Philadelphia area. As an Inc. 500 honoree, DSG shares a prestigious pedigree with such notable companies as Intuit, Microsoft, and Oracle.

HUMAN GENOME ACHIEVES LUPUS DRUG GOALS WITH DSG’S EDC

Human Genome Sciences (HGS: NASDAQ: HGSI) announced that BENLYSTA™ met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). These results show that BENLYSTA™ has the potential to become the first new approved drug in decades giving hope to people living with systemic lupus.

DSG ANNOUNCES RECORD GROWTH FOR THE FIRST HALF OF 2009

DSG Inc., an industry leader in clinical trial data collection and management, today announced, from the 45th Annual Meeting of the Drug Information Association, its continued record growth and profitability for the first half of 2009.

DSG CEO TONY VARANO NAMED ERNST & YOUNG ENTREPRENEUR OF THE YEAR 2009 IN GREATER PHILADELPHIA

DSG, Inc. today announced that CEO Tony Varano is a finalist for the Ernst & Young Entrepreneur Of The Year® 2009 Award in the Greater Philadelphia. According to Ernst & Young LLP, the awards program recognizes entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities. Mr. Varano was selected as a finalist from nearly 40 nominations by a panel of independent judges. Award winners will be announced at a special gala event on June 18, 2009 at the Loews Hotel.

DSG has a strong history of customer success in deploying the latest in electronic data capture (EDC) software and services since 1992 and a customer list including four of the five largest pharmaceutical companies in the world.

DSG TO EXHIBIT LATEST IN ELECTRONIC DATA CAPTURE AT 18th ANNUAL PARTNERSHIPS WITH CROs CONFERENCE

DSG Inc., an industry leader in clinical trial data collection and management, will be exhibiting at the 18th Annual Partnerships with CROs Conference at the Orlando Rosen Shingle Creek Hotel and Conference Center, April 28-30, 2009.

DSG TO HOST ANNUAL USER'S GROUP MEETING

DSG. Inc., an industry leader in clinical trial data collection and management, today announced that it will host its annual User’s Group Meeting on March 26, 2009 at the Trump Plaza Hotel and Casino in Atlantic City, N.J.

DSG WINS SCDM'S DATA DRIVEN INNOVATION AWARD FOR CLINICAL DATA QUALITY CONTROL IMPLEMENATION AT HUMAN GENOME SCIENCES

DSG. Inc., an industry leader in clinical trial data collection and management, today announced that its collaborative work with Human Genome Sciences (HGS) was selected as the second place winner in the 2008 Society For Clinical Data Management (SCDM) Data Driven Innovation Award competition.